By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...
Ren Jinsheng, founder and chairman of Simcere Pharmaceutical Group, said during an event held in April that China has unique ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
China Medical System Holdings Limited (867.HK/8A8.SG) ('CMS”, or the 'Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the 'Product”), a Class 1 ...
With the aging of the global population and the rising incidence of neuropsychiatric conditions, the demand for therapeutic drugs is increasing. Consequently, innovations relevant to these medications ...
Pediatric drug development faces significant challenges, including underfunding, ethical concerns, and complex regulatory frameworks. Despite significant advances in adult drug development, children ...
Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...
(Yicai) June 23 -- Haisco Pharmaceutical Group's shares jumped after the drugmaker granted US' Nuvectis Pharma the exclusive ...
An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and ...
Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...
Pharma R&D is at a crossroads: the pressure to accelerate innovation, ensure compliance and manage fragmented data has never ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results